ASSOCIATION OF ABC POLYMORPHISM WITH ANTIEMETIC EFFICACY IN CANCER PATIENTS TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY

被引：0
|
作者：
Tsuji, Daiki [1 ]
Kim, Yong-Il [2 ]
Daimon, Takashi [3 ]
Makuta, Ryo [1 ]
Homma, Chiho [2 ]
Nakamichi, Hidenori [4 ]
Yamamoto, Keisuke [4 ]
Hayashi, Hideki [1 ]
Inoue, Kazuyuki [1 ]
Itoh, Kunihiko [1 ]
机构：
[1] Univ Shizuoka, Dept Clin Pharmacol & Genet, Shizuoka 4228526, Japan
[2] Seirei Hamamatsu Gen Hosp, Dept Med Oncol, Hamamatsu, Shizuoka, Japan
[3] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo, Japan
[4] Seirei Hamamatsu Gen Hosp, Dept Pharm, Hamamatsu, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-26-1
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy—a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines
    Shiying Yu
    Thomas A. Burke
    Alexandre Chan
    Hoon-Kyo Kim
    Ruey Kuen Hsieh
    Xichun Hu
    Jin-Tung Liang
    Ana Baños
    Carmel Spiteri
    Dorothy M. K. Keefe
    Supportive Care in Cancer, 2015, 23 : 273 - 282
  • [42] Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
    Yu Kondo
    Tomoya Tachi
    Takayoshi Sakakibara
    Jun Kato
    Takahito Mizuno
    Yoshio Miyake
    Hitomi Teramachi
    Journal of Pharmaceutical Health Care and Sciences, 8
  • [43] Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
    Kondo, Yu
    Tachi, Tomoya
    Sakakibara, Takayoshi
    Kato, Jun
    Mizuno, Takahito
    Miyake, Yoshio
    Teramachi, Hitomi
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2022, 8 (01)
  • [44] A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
    Takada, S.
    Tsuji, D.
    Kawaguchi, T.
    Yokokawa, T.
    Kawasaki, Y.
    Yamaguchi, T.
    Tamaki, S.
    Koizumi, K.
    Matsumoto, T.
    Sakata, Y.
    Arakawa, Y.
    Ayuhara, H.
    Yamaguchi, M.
    Suzuki, W.
    Watanabe, K-I.
    Hosonaga, M.
    Nakagaki, S.
    Hatori, M.
    Osawa, M.
    Suzuki, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1100 - S1100
  • [45] Antiemetic use and chemotherapy induced nausea and vomiting related hospitalization costs after highly or moderately emetogenic chemotherapy
    Nelson, Winnie W.
    Vaidya, Varun
    Scott, Jeffery A.
    Wang, Brandon
    Lambert, Hunter
    Holmes, Benjamin
    Bailey, William L.
    FUTURE ONCOLOGY, 2023, 19 (01) : 29 - 36
  • [46] SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013
    J. García Gómez
    M. E. Pérez López
    M. Alonso Bermejo
    Y. Escobar Álvarez
    J. García Mata
    Clinical and Translational Oncology, 2013, 15 : 1030 - 1036
  • [47] Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy-a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines
    Yu, Shiying
    Burke, Thomas A.
    Chan, Alexandre
    Kim, Hoon-Kyo
    Hsieh, Ruey Kuen
    Hu, Xichun
    Liang, Jin-Tung
    Banos, Ana
    Spiteri, Carmel
    Keefe, Dorothy M. K.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (01) : 273 - 282
  • [48] Adherence to antiemetic guidelines for highly emetogenic chemotherapy - a retrospective representative sample survey and analysis in Germany
    Link, H.
    Nietsch, J.
    Kerkmann, M.
    Jordan, K.
    Ortner, P.
    Oncology Research and Treatment, 2015, 38 : 192 - 192
  • [49] Comparative study between the clinical effect of palonosetron and granisetron as antiemetic therapy for patients receiving highly emetogenic chemotherapy regimens
    Mahrous, M. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S86 - S87
  • [50] SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013
    Garcia Gomez, J.
    Perez Lopez, M. E.
    Alonso Bermejo, M.
    Escobar Alvarez, Y.
    Garcia Mata, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (12): : 1030 - 1036
12345